sofosbuvir has been researched along with B-Cell Lymphoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alric, L; Arcaini, L; Besson, C; Bruno, R; Carrat, F; Casato, M; Dorival, C; Fabris, P; Ferretti, VV; Fontaine, H; Frigeni, M; Goldaniga, M; Hermine, O; Jaccard, A; Loustaud-Ratti, V; Merli, M; Peveling-Oberhag, J; Pol, S; Rattotti, S; Rigacci, L; Rossotti, R; Torres, HA; Visco, C; Visentini, M; Zaja, F | 1 |
1 trial(s) available for sofosbuvir and B-Cell Lymphoma
| Article | Year |
|---|---|
Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection.
Topics: Antiviral Agents; Disease-Free Survival; Female; Hepatitis C, Chronic; Humans; Lymphoma, B-Cell; Male; Middle Aged; Retrospective Studies; Sofosbuvir; Survival Rate | 2016 |